Drug General Information
Drug ID
D07TXJ
Former ID
DCL000772
Drug Name
Dextofisopam
Synonyms
R-Tofisopam; Dextofisopam (USAN/INN); (5R)-1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine
Drug Type
Small molecular drug
Indication Irritable bowel syndrome [ICD9: 564.1, 787.91; ICD10:A09, K58, K59.1] Phase 2 [536224]
Company
Vela Pharmaceuticals
Structure
Download
2D MOL

3D MOL

Formula
C22H26N2O4
Canonical SMILES
CCC1C(=NN=C(C2=CC(=C(C=C12)OC)OC)C3=CC(=C(C=C3)OC)OC)C
InChI
1S/C22H26N2O4/c1-7-15-13(2)23-24-22(14-8-9-18(25-3)19(10-14)26-4)17-12-21(28-6)20(27-5)11-16(15)17/h8-12,15H,7H2,1-6H3/t15-/m0/s1
InChIKey
RUJBDQSFYCKFAA-HNNXBMFYSA-N
CAS Number
CAS 82059-50-5
PubChem Compound ID
PubChem Substance ID
SuperDrug ATC ID
A10BG03
SuperDrug CAS ID
cas=111025468
Target and Pathway
Target(s) Peripheral-type benzodiazepine receptor Target Info Agonist [536224]
Gamma-aminobutyric acid receptor Target Info Agonist [536224]
KEGG Pathway Neuroactive ligand-receptor interaction
HTLV-I infection
References
Ref 536224Emerging drugs for irritable bowel syndrome. Expert Opin Emerg Drugs. 2006 May;11(2):293-313.
Ref 536224Emerging drugs for irritable bowel syndrome. Expert Opin Emerg Drugs. 2006 May;11(2):293-313.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.